Somatic GNAS mutations in acromegaly: prevalence, clinical features and gender differences
Open Access
- 8 November 2024
- journal article
- research article
- Published by Bioscientifica in Endocrine Connections
- Vol. 14 (1)
Abstract
Background: Somatic GNAS mutations are acknowledged as a significant etiological factor for acromegaly. However, the relationship between GNAS mutation status, clinical characteristics and gender has not been adequately investigated. This study aims to address these gaps by examining GNAS mutations and delineating the detailed clinical profile of affected patients within a Chinese acromegaly cohort.Methods: Our study encompassed 97 individuals newly diagnosed with acromegaly who underwent surgical treatment between May 2015 and January 2022. We obtained DNA from frozen pituitary adenomas to screen for GNAS hotspot mutations and assessed the associated clinical characteristics.Results: In our cohort, 44.3% (43/97) of patients exhibited somatic GNAS mutations. Patients with mutations were predominantly male (58.1 vs 33.3%, P = 0.015), experienced longer diagnosis delays (72.0 (48.0, 120.0) vs 36.0 (21.0, 75.0) months, P = 0.002), had smaller maximum tumor diameters (1.75 ± 0.83 vs 2.23 ± 0.89 cm, P = 0.008) and demonstrated higher rates of growth hormone (GH) secretion per unit tumor volume (18.93 (9.67, 30.12) vs 10.91 (2.80, 20.40) ng/mL cm−3, P = 0.005). Regarding gender-specific differences, GNAS mutations in male patients were linked to significantly higher baseline GH levels (24.40 (14.40, 36.30) vs 10.55 (5.25, 16.95) ng/mL, P = 0.002), while female patients with mutations had notably smaller tumor sizes (1.55 ± 0.55 cm vs 2.32 ± 0.85 cm, P < 0.001).Conclusion: GNAS mutations are prevalent among Chinese acromegaly patients, correlating with reduced pituitary tumor sizes and enhanced GH secretion functions. Our findings underscore the influence of gender on the clinical manifestations of GNAS mutations. Accordingly, we recommend that future clinical and foundational research studies on acromegaly give heightened consideration to gender-specific differences.Keywords
This publication has 25 references indexed in Scilit:
- The genetic background of acromegalyPituitary, 2017
- Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomasEuropean Journal of Endocrinology, 2017
- Different Volumetric Measurement Methods for Pituitary Adenomas and Their Crucial Clinical SignificanceScientific Reports, 2017
- The genome-wide mutational landscape of pituitary adenomasCell Research, 2016
- Landscape of somatic mutations in sporadic GH-secreting pituitary adenomasEuropean Journal of Endocrinology, 2016
- Whole-Genome Sequencing of Growth Hormone (GH)-Secreting Pituitary AdenomasThe Journal of Clinical Endocrinology & Metabolism, 2015
- The Metabolic Profile in Active Acromegaly is Gender-SpecificThe Journal of Clinical Endocrinology & Metabolism, 2013
- Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remissionPituitary, 2007
- GSPα mutations in Mexican patients with acromegaly: potential impact on long term prognosisGrowth Hormone & IGF Research, 2005
- Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.1998